trending Market Intelligence /marketintelligence/en/news-insights/trending/z0d_cyovapdx0bk8glmxzq2 content esgSubNav
In This List

Avinger regains Nasdaq compliance

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Avinger regains Nasdaq compliance

Avinger Inc. said it regained compliance with Nasdaq listing requirements.

The Redwood City, Calif.-based medical device company is now compliant with Nasdaq rules related to minimum bid price, market value of publicly held shares and market value of listed securities.

Avinger was informed of noncompliance with Nasdaq's minimum bid price requirement in May 2017, after which it received an extension notice in January.